Skip to main content

Table 4 Comparison in efficacy and safety between the two study periods

From: Comparison between regional citrate anticoagulation and heparin for intermittent hemodialysis in ICU patients: a propensity score-matched cohort study

Variables IHD sessions in 2015 (n = 116) IHD sessions in 2017 (n = 92) p-value
IHD session with RCA, n (%) 76 (65.5) 48 (52.1) 0.97
Kt/V at the end of session 0.93 ± 0.35 0.92 ± 0.38 0.84
Kt/V at the end of session with RCA 0.97 ± 0.37 0.91 ± 0.41 0.72
Kt/V at the end of session with heparin 0.86 ± 0.30 0.92 ± 0.33 0.59
Causes of premature termination of session, n(%)
 Acute high transmembrane pressure 21(18) 11 (12) 0.23
 Circuit clotting 11 (9.5) 7 (7.6) 0.63
  1. RCA, regional citrate anticoagulation, IHD, intermittent hemodialysis